Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 1998, p. 951-952, Vol. 42, No. 4
Division of Infectious Diseases, Department
of Pediatrics, State University of New York, Health Science Center
at Brooklyn, Brooklyn, New York 11203
Received 10 October 1997/Accepted 5 February 1998
The in vitro susceptibilities of 10 strains of Chlamydia
pneumoniae to a new 8-methoxyquinolone, BAY 12-8039, and to
ofloxacin, doxycycline, and erythromycin were determined. The activity
of BAY 12-8039 was similar to that of ofloxacin, with a MIC at which 90% of the isolates had no inclusions and a minimal chlamydicidal concentration at which 90% of the isolates had no inclusions after passage of 1.0 µg/ml, but this activity was less than those of doxycycline and erythromycin.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vitro Activity of a New 8-Methoxyquinolone,
BAY 12-8039, against Chlamydia pneumoniae
*
Corresponding author. Mailing address: Department of
Pediatrics, Box 49, SUNY Health Science Center at Brooklyn, 450 Clarkson Ave., Brooklyn, NY 11203-2098. Phone: (718) 245-4075. Fax:
(718) 245-2118. E-mail: mhammerschlag{at}pol.net.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |